The Evolution of Population-Based Cancer Registries in Iran: A 70-Year Journey
Abstract
data on cancer incidence, prevalence, and mortality. This paper reviews the development, current status, and challenges of the Population-Based Cancer Registry (PBCR) program in Iran. Since the 1950s, Iran has made significant efforts to establish systematic cancer registration, culminating in the expansion of PBCRs across multiple provinces. The Golestan Province Cancer Registry was the first Iranian registry included in the international Cancer Incidence in Five Continents (CI5) report in 2014, with Ardabil Province joining in 2023, reflecting growing international recognition. The Iranian PBCR program has evolved through national legislation mandating cancer reporting, expansion from pathology-based to population-based registries, and continuous quality improvement initiatives. Despite progress, challenges remain, including underreporting, data completeness, and timeliness. The most recent national PBCR report (2018) documented approximately 141,000 new cancer cases with age-standardized incidence rates of 182.8 and 165.3 per 100,000 for men and women, respectively. Regional disparities were evident, with higher rates of oesophageal, stomach, and lung cancers in northern provinces and breast, colorectal, and prostate cancers more common centrally. Projections indicate a 42.6% increase in new cancer cases by 2025, underscoring the urgent need for enhanced cancer control strategies. Survival analyses reveal substantial variation by cancer type and region, with higher survival in provinces with better socioeconomic indicators. Furthermore, modifiable risk factors such as smoking, overweight, opium use, and Helicobacter pylori infection contribute significantly to cancer burden in Iran. To strengthen the PBCR program, priorities include timely publication of reports, improving data quality and coverage, and expanding international certification and publication. Sustained political commitment and resource allocation are essential to optimize cancer surveillance and support evidence-based policy to reduce Iran’s growing cancer burden.Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2024;74(3):229-63.
Jensen OM. Cancer registration: principles and methods: IARC; 1991.
Bray F CM, Aitken JF, Bardot A, Eser S, Galceran J, Hagenimana M, Matsuda T, Mery L, Piñeros M, Soerjomataram I, de Vries E, Wiggins C, Won YJ, Znaor A and Ferlay J. Cancer Incidence in Five Continents Volume XII: IARC Scientific Publications; 2024.
Foreman D, Bray F, Brewster D, Gombe Mbalawa C, Kohler B, Pineros M. Cancer Incidence in Five Continents. Volume X. Lyon. International Agency for Research on Cancer. 2014.
Habibi A. Cancer in Iran. A survey of the most common cases. Journal of the National Cancer Institute. 1965;34(5):553-69.
Etemadi A, Sajadi A, Semnani S, NOURAEI SM, Khademi H, Bahadori M. Cancer registry in Iran: a brief overview. 2008.
Kmet J, Mahboubi E. Esophageal Cancer in the Caspian Littoral of Iran: Initial Studies: Detailed studies of geographical pathology are opening new vistas in cancer epidemiology. Science. 1972;175(4024):846-53.
Mandatory sRoIPL, Cancer. Ro. [Available from: from: URL:
http://lawoffice.mohme.gov.ir. .
Zendehdel K, Sedighi Z, Hassanloo J, Nahvijou A. Improving quality of cancer registration in Iran. Part1: evaluation and comparison of cancer registration results in the country. Hakim Journal. 2010;12(4):42-9.
Zendehdel K, Sedighi Z, Hassanloo J, Nahvijou A. Audit of a nationwide pathology-based cancer registry in Iran. Basic & Clinical Cancer Research. 2011;3(2):7-13.
Zendehdel K, Hassanloo J, Sedighi Z, Nahvijoo A, Malekzadeh R, Mohagheghi M. Improving quality of cancer registration in iran. Part2: Suggesting new national cancer registration program in iran, based on comparative study of 18 countries. Hakim Journal. 2010;12(4):50-7.
Mohagheghi MA, Mosavi-Jarrahi A. Review of cancer registration and cancer data in Iran, a historical prospect. Asian Pac J Cancer Prev. 2010;11(4):1155-7.
Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M, et al. Cancer occurrence in Ardabil: Results of a population‐based Cancer Registry from Iran. International journal of cancer. 2003;107(1):113-8.
Alireza S, Mehdi N, Ali M, Alireza M, Reza M, Parkin D. Cancer occurrence in Iran in 2002, an international perspective. Asian Pacific journal of cancer prevention. 2005;6(3):359.
Semnani S, Sadjadi A, Fahimi S, Nouraie M, Naeimi M, Kabir J, et al. Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance. Cancer detection and prevention. 2006;30(1):14-9.
Babaei M, Mousavi S, Toussy J. Cancer occurrence in old age: Results of a population-based cancer registry in Semnan, Iran. Asian Pacific Journal of Cancer Prevention. 2006:191-4.
Somi MH, Farhang S, Kazem Mirinezhad S, Naghashi S, Seif-Farshad M, Golzari M. Cancer in East Azerbaijan, Iran: results of a population-based cancer registry. Asian Pacific Journal of Cancer Prevention. 2008;9(2):327-30.
Ministry of Health and Medical education Doh, Non-communicable diseases control department, cancer office. Annual Report of Iranian National population-based Cancer registry. 2003.
Ministry of Health and Medical education Doh, Non-communicable diseases control department, cancer office. . Annual Report of Iranian National population-based Cancer registry. ISBN: : 978-600-333-517-2. 2018.
Roshandel G, Ferlay J, Ghanbari‐Motlagh A, Partovipour E, Salavati F, Aryan K, et al. Cancer in Iran 2008 to 2025: recent incidence trends and short‐term predictions of the future burden. International journal of cancer. 2021;149(3):594-605.
Pejman Sani M, Mohseni S, Samimi H, Nasiri S, Fallahi B, Mohajeri-Tehrani M, et al. Continued rise in the incidence of thyroid cancer in Iran: true increase or overdiagnosis? Journal of Diabetes & Metabolic Disorders. 2025;24(1):68.
Mousavian A-H, Shafiee G, Sheidaei A, Balajam NZ, Ebrahimi M, Khatami F, et al. The 15-year national trends of urinary cancers incidence among Iranian men and women; 2005–2020. International Journal for Equity in Health. 2024;23(1):13.
Iranfar K, Mokhayeri Y, Mohammadi G. Time trend analysis of oral cancer in Iran from 2005 to 2010. Asian Pacific Journal of Cancer Prevention. 2016;17(3):1421-6.
Sepandi M, Alimohamadi Y. Comparing the trend of colorectal cancer before and after the implementation of the Population-Based National Cancer Registry in Iran. Journal of Preventive Medicine and Hygiene. 2025;65(4):E515.
Pakzad R, Rafiemanesh H, Ghoncheh M, Sarmad A, Salehiniya H, Hosseini S, et al. Prostate cancer in Iran: trends in incidence and morphological and epidemiological characteristics. Asian Pacific Journal of Cancer Prevention. 2016;17(2):839-43.
Asgarian FS, Mahdian M, Amori N. Epidemiology and trends of gastrointestinal cancer in Iran (2004–2008). Journal of Cancer Research and Therapeutics. 2021;17(4):963-8.
Bab S, Abdifard E, Elyasianfar S, Mohammadi P, Heidari M. Time trend analysis of breast cancer in Iran and its six topographical regions: a population-based study. Journal of medicine and life. 2019;12(2):140.
Nemati S, Saeedi E, Lotfi F, Nahvijou A, Mohebbi E, Ravankhah Z, et al. National surveillance of cancer survival in Iran (IRANCANSURV): Analysis of data of 15 cancer sites from nine population‐based cancer registries. International Journal of Cancer. 2022;151(12):2128-35.
Nemati S, Saeedi E, Lotfi F, Nahvijou A, Pirnejad H, Cheraghi M, et al. Regional disparities in cancer survival in Iran: Insight from a National Surveillance of Cancer Survival in Iran (IRANCANSURV). Cancer Epidemiology. 2023;85:102378.
Nemati S, Mohebbi E, Toorang F, Hadji M, Hosseini B, Saeedi E, et al. Population attributable proportion and number of cancer cases attributed to potentially modifiable risk factors in Iran in 2020. International journal of cancer. 2023;153(10):1758-65.
Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. European journal of cancer. 2009;45(5):747-55.
Mohammadi G, Akbari ME, Mehrabi Y, Ghanbari Motlagh A, Partovi Pour E, Roshandel G, et al. Estimating completeness of cancer registration in Iran with capture-recapture methods. Asian Pacific Journal of Cancer Prevention. 2016;17(S3):93-9.
Roshandel G, Ghanbari-Motlagh A, Partovipour E, Salavati F, Hasanpour-Heidari S, Mohammadi G, et al. Cancer incidence in Iran in 2014: results of the Iranian National Population-based Cancer Registry. Cancer epidemiology. 2019;61:50-8.
Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. European journal of cancer. 2009;45(5):756-64.
Cheshmeh ZMH, Ostovar A, Motlagh AG, Asadi-Lari M. Examining the Completeness of Breast Cancer Pathology Reports Registered in the Population-Based Cancer Registration System in Iran during 2016 to 2018. Medical Journal of the Islamic Republic of Iran. 2024;38:61.
Ministry of Health and Medical education Doh, Non-communicable diseases control department, cancer office. . Annual Report of Iranian National population-based Cancer registry. ISBN: 978 - 600-333-346 -8. 2014.
Ministry of Health and Medical education Doh, Non-communicable diseases control department, cancer office. . Annual Report of Iranian National population-based Cancer registry. ISBN: 978-600-333-372-7. 2015.
Ministry of Health and Medical education Doh, Non-communicable diseases control department, cancer office. . Annual Report of Iranian National population-based Cancer registry. ISBN: 978 -600-333-444-1. 2016.
Ministry of Health and Medical education Doh, Non-communicable diseases control department, cancer office. . Annual Report of Iranian National population-based Cancer registry. ISBN: 978-600-333-446-5. 2017.
Jackson A, Virdee PS, Tonner S, Oke JL, Perera R, Riahi K, et al. Validity and timeliness of cancer diagnosis data collected during a prospective cohort study and reported by the English and Welsh cancer registries: a retrospective, comparative analysis. The Lancet Oncology. 2024;25(11):1476-86.
Giusti F, Martos C, Negrão Carvalho R, Van Eycken L, Visser O, Bettio M. Quality indicators: completeness, validity and timeliness of cancer registry data contributing to the European Cancer Information System. Frontiers in Oncology. 2023;13:1219128.
| Files | ||
| Issue | Vol 16 No 4 (2024) | |
| Section | Reviews | |
| Keywords | ||
| Population-Based Cancer Registry: Iran; History | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
